What procurement, compliance, and clinical leaders should ask before scaling a documentation AI
Documentation-assisted artificial intelligence (AI), often called an AI scribe, promises to cut clinician time in notes and reduce after-hours work. What matters to operations is not the slogan but what actually changes in coding, clinician workload, and auditability when the tool is deployed. Recent reporting that three health systems reported revenue gains after deploying an ambient AI scribe is a reminder that these tools can alter evaluation and management (E/M) coding at scale, for better or worse. The practical question for leaders is what to measure and what answers from a vendor look like versus what should trigger a pause.
Here are the vendor-focused questions to write down before you sign a contract, and the kinds of answers that reduce downstream surprises. These are procurement-style checklists, not technical specs, and they are shaped for clinical and finance leads who need plain, operational assurances.
How did you validate the coding changes the scribe produced?
Vendors will point to efficiency and clinician satisfaction. Ask for independent validation of coding shifts and a clear description of the review process that produced those conclusions. A careful answer names the reviewers, the sample size and mix of specialties, and how much manual review went into the result. An evasive answer says only “clients saw revenue gains” without explaining the mechanism.
- What the right answer sounds like: a third-party audit or peer-reviewed evaluation that compares pre- and post-deployment notes for the same encounters, with blinded coding review and clear inclusion criteria.
- Red flag: pooled statistics from a small pilot being presented as enterprise-wide outcomes.
- Operational follow-up: ask for a way to reproduce the validation on your data, not just summary slides.
Can we see the audit trail and how coding decisions are derived?
When documentation changes lead to higher-intensity codes, auditors and payers will ask “why.” You need a defensible record that explains how the note ended up the way it did. That means access to the note drafts, timestamps showing clinician review, and a readable chain of evidence linking audio, transcription, and the final note. Ask who owned each step and who attested to the note.
Good answers acknowledge documentation provenance and describe how the system preserves an auditable record. Ask how clinician edits are tracked, how long intermediate artifacts are retained, and who can retrieve them. If Health Insurance Portability and Accountability Act (HIPAA) guidance matters for your program, tie the audit conversation to your compliance policies by asking for examples of how patient data is protected while preserving auditability. Where call or session recordings are part of the workflow, treat the vendor’s position on call recording compliance as part of the procurement answer.
What did the pilot actually measure and when does expansion make sense?
Pilot reports often list time-savings, clinician satisfaction, and financial outcomes. Drill into which of those were primary endpoints, how the cohort was selected, and whether specialists, emergency medicine, and primary care were analyzed separately. Expansion criteria should be explicit: what minimum effect on clinician workload is required, what coding variance is acceptable, and what monitoring will remain in place once you go broader.
Look for vendors who describe operational guardrails as part of the rollout plan. That includes ongoing clinician feedback channels, routine spot audits of coded encounters, and predefined escalation paths if coding percentiles drift. Ask for a cadence of post-deployment reviews and a list of metrics that will trigger a pause. Also consider whether your workflows need complementary controls, for example a secure way for clinicians to flag and fix mis-summarized encounters without adding administrative overhead.
When patient outcomes, patient-reported outcome (PRO) capture, or patient experience surveys intersect with documentation changes, be mindful that downstream measures can shift. Changes in documentation might influence coded complexity or the apparent case mix. If you run patient-facing surveys or Patient-Reported Outcomes Measurement Information System (PROMIS) surveys, map how the documentation tool could affect perceived quality, and plan for a baseline recheck after deployment.
What to monitor continuously once the tool is in place
The honest answer is that you cannot treat a successful pilot as permanent proof. What matters is the monitoring plan. Prioritize a short list of operational indicators that are easy to report and hard to game: clinician time spent in notes, percent of encounters with post-visit edits, distribution of E/M code levels by specialty, and a rolling sample of blinded chart reviews. Make sure the vendor agrees to share the data feeds or reports you need to run those checks without requiring a heavy lift from your IT team.
Plan for the soft work too. Clinicians need a clear policy on when they must review and sign AI-drafted notes. Coding and revenue teams need a shared rubric for acceptable change. Compliance should be able to retrieve an auditable record on demand. These are organizational decisions, not technology ones, but the technology must make them possible.
We see this pattern repeat across health systems: the initial numbers can look promising, but without agreed validation, retained artifacts, and expansion rules, leaders end up arguing about intent rather than evidence. Asking the vendor the questions above before you expand keeps the conversation grounded in operations rather than marketing. For teams that work on documentation, patient surveys, and follow-up programs, it is useful to pair your vendor diligence with operational checks used in related programs, such as PROMIS patient-reported outcome surveys, to ensure changes in documentation do not unintentionally alter downstream measurement or patient experience.